Osteoblastic differentiation of mesenchymal stem cells by mumie extract

Cho Rok Jung, Igor A. Schepetkin, Sang B. Woo, Andrey Ivanovich Khlebnikov, Byoung S. Kwon

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Mumie, a plant humus matter from rocks, is known as anabolic and a stimulator of bone regeneration in the Russian and Indian systems of health and medicine. The water-soluble fraction of mumie from Uzbekistan was characterized using 1H NMR and infrared spectroscopic methods. The mumie extract has been investigated for its effect on osteoblastic differentiation in cell culture assays of human and murine mesenchymal stem cells. The calcium deposition and expression of alkaline phosphatase, osteocalcin, core binding factor 1 (Cbfa1), and ERK have been studied. During the 14-day assay period, human bone marrow mesenchymal stem cells (hMSCs) and human fetal osteoblasts cultured with mumie (3-5 μg/ml) underwent a dramatic change in cellular morphology, which was accompanied by a significant increase in alkaline phosphatase activity, calcium deposition, and osteocalcin expression. The expression of core binding factor 1 and ERK were enhanced in hMSCs and murine pluripotent mesenchymal precursor cell line C2C12. Dose-dependent decrease in TRAP-positive multinucleated cell formation from macrophage-like cells RAW 264.7 was observed with increasing concentration of mumie in the presence of RANKL (40 ng/ml) and PD98059 (10 μM), a specific inhibitor of ERK activity. The data suggest that mumie is a potent stimulator of osteoblastic differentiation of mesenchymal stem cells and inhibitor of osteoclastogenesis, hence it maybe of clinical benefit in the treatment for osteoporosis in human.

Original languageEnglish
Pages (from-to)122-133
Number of pages12
JournalDrug Development Research
Volume57
Issue number3
DOIs
Publication statusPublished - 1 Nov 2002
Externally publishedYes

Fingerprint

Cell Extracts
Stem cells
Mesenchymal Stromal Cells
Core Binding Factors
Bone
Osteocalcin
Alkaline Phosphatase
Assays
Bone Marrow
Uzbekistan
Calcium
Bone Regeneration
Macrophages
Osteoblasts
Systems Analysis
Cell culture
Osteogenesis
Osteoporosis
Medicine
mumie

Keywords

  • Humic substances
  • Mesenchymal stem cells
  • Mumie
  • Osteoblasts
  • Osteoclasts

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Osteoblastic differentiation of mesenchymal stem cells by mumie extract. / Jung, Cho Rok; Schepetkin, Igor A.; Woo, Sang B.; Khlebnikov, Andrey Ivanovich; Kwon, Byoung S.

In: Drug Development Research, Vol. 57, No. 3, 01.11.2002, p. 122-133.

Research output: Contribution to journalArticle

@article{65fe0adda7b84ca0bd9b8f466145edd1,
title = "Osteoblastic differentiation of mesenchymal stem cells by mumie extract",
abstract = "Mumie, a plant humus matter from rocks, is known as anabolic and a stimulator of bone regeneration in the Russian and Indian systems of health and medicine. The water-soluble fraction of mumie from Uzbekistan was characterized using 1H NMR and infrared spectroscopic methods. The mumie extract has been investigated for its effect on osteoblastic differentiation in cell culture assays of human and murine mesenchymal stem cells. The calcium deposition and expression of alkaline phosphatase, osteocalcin, core binding factor 1 (Cbfa1), and ERK have been studied. During the 14-day assay period, human bone marrow mesenchymal stem cells (hMSCs) and human fetal osteoblasts cultured with mumie (3-5 μg/ml) underwent a dramatic change in cellular morphology, which was accompanied by a significant increase in alkaline phosphatase activity, calcium deposition, and osteocalcin expression. The expression of core binding factor 1 and ERK were enhanced in hMSCs and murine pluripotent mesenchymal precursor cell line C2C12. Dose-dependent decrease in TRAP-positive multinucleated cell formation from macrophage-like cells RAW 264.7 was observed with increasing concentration of mumie in the presence of RANKL (40 ng/ml) and PD98059 (10 μM), a specific inhibitor of ERK activity. The data suggest that mumie is a potent stimulator of osteoblastic differentiation of mesenchymal stem cells and inhibitor of osteoclastogenesis, hence it maybe of clinical benefit in the treatment for osteoporosis in human.",
keywords = "Humic substances, Mesenchymal stem cells, Mumie, Osteoblasts, Osteoclasts",
author = "Jung, {Cho Rok} and Schepetkin, {Igor A.} and Woo, {Sang B.} and Khlebnikov, {Andrey Ivanovich} and Kwon, {Byoung S.}",
year = "2002",
month = "11",
day = "1",
doi = "10.1002/ddr.10120",
language = "English",
volume = "57",
pages = "122--133",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Osteoblastic differentiation of mesenchymal stem cells by mumie extract

AU - Jung, Cho Rok

AU - Schepetkin, Igor A.

AU - Woo, Sang B.

AU - Khlebnikov, Andrey Ivanovich

AU - Kwon, Byoung S.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Mumie, a plant humus matter from rocks, is known as anabolic and a stimulator of bone regeneration in the Russian and Indian systems of health and medicine. The water-soluble fraction of mumie from Uzbekistan was characterized using 1H NMR and infrared spectroscopic methods. The mumie extract has been investigated for its effect on osteoblastic differentiation in cell culture assays of human and murine mesenchymal stem cells. The calcium deposition and expression of alkaline phosphatase, osteocalcin, core binding factor 1 (Cbfa1), and ERK have been studied. During the 14-day assay period, human bone marrow mesenchymal stem cells (hMSCs) and human fetal osteoblasts cultured with mumie (3-5 μg/ml) underwent a dramatic change in cellular morphology, which was accompanied by a significant increase in alkaline phosphatase activity, calcium deposition, and osteocalcin expression. The expression of core binding factor 1 and ERK were enhanced in hMSCs and murine pluripotent mesenchymal precursor cell line C2C12. Dose-dependent decrease in TRAP-positive multinucleated cell formation from macrophage-like cells RAW 264.7 was observed with increasing concentration of mumie in the presence of RANKL (40 ng/ml) and PD98059 (10 μM), a specific inhibitor of ERK activity. The data suggest that mumie is a potent stimulator of osteoblastic differentiation of mesenchymal stem cells and inhibitor of osteoclastogenesis, hence it maybe of clinical benefit in the treatment for osteoporosis in human.

AB - Mumie, a plant humus matter from rocks, is known as anabolic and a stimulator of bone regeneration in the Russian and Indian systems of health and medicine. The water-soluble fraction of mumie from Uzbekistan was characterized using 1H NMR and infrared spectroscopic methods. The mumie extract has been investigated for its effect on osteoblastic differentiation in cell culture assays of human and murine mesenchymal stem cells. The calcium deposition and expression of alkaline phosphatase, osteocalcin, core binding factor 1 (Cbfa1), and ERK have been studied. During the 14-day assay period, human bone marrow mesenchymal stem cells (hMSCs) and human fetal osteoblasts cultured with mumie (3-5 μg/ml) underwent a dramatic change in cellular morphology, which was accompanied by a significant increase in alkaline phosphatase activity, calcium deposition, and osteocalcin expression. The expression of core binding factor 1 and ERK were enhanced in hMSCs and murine pluripotent mesenchymal precursor cell line C2C12. Dose-dependent decrease in TRAP-positive multinucleated cell formation from macrophage-like cells RAW 264.7 was observed with increasing concentration of mumie in the presence of RANKL (40 ng/ml) and PD98059 (10 μM), a specific inhibitor of ERK activity. The data suggest that mumie is a potent stimulator of osteoblastic differentiation of mesenchymal stem cells and inhibitor of osteoclastogenesis, hence it maybe of clinical benefit in the treatment for osteoporosis in human.

KW - Humic substances

KW - Mesenchymal stem cells

KW - Mumie

KW - Osteoblasts

KW - Osteoclasts

UR - http://www.scopus.com/inward/record.url?scp=0036869758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036869758&partnerID=8YFLogxK

U2 - 10.1002/ddr.10120

DO - 10.1002/ddr.10120

M3 - Article

VL - 57

SP - 122

EP - 133

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 3

ER -